Are the new ‘diabetes’ medicine really cardiology drugs?

3 September 2019 (13:15 - 13:20)

Organised by:

About the speakers

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

3 More presentations in this session

Presentation thumbnail

Guidelines on diabetes, pre-diabetes and cardiovascular diseases in a nutshell

Professor F. Cosentino (Stockholm, SE)

Presentation thumbnail

The diabetes challenge for cardiologists

Professor F. Krag Knop (Copenhagen, DK)

Presentation thumbnail

Challenge the experts: panel and audience discussion

Professor F. Krag Knop (Copenhagen, DK) Professor F. Cosentino (Stockholm, SE) Professor J. Deanfield (London, GB) Professor N. Marx (Aachen, DE)

Access the full session

Session thumbnail

Impact of novel guidelines: transforming diabetes management in cardiology

The Event

ESC Congress 2019

3 September 2019 13:15 CET

You may be interested in

Congress Presentation

Novel multidisciplinary cardiometabolic clinic in a UK tertiary cardiology centre: early activity, interventions and potential for cardiovascular risk optimisation

27 August 2021

Congress Presentation

Medical treatment in prediabetes to reduce CV risk and avoid transitioning to diabetes - What is the optimal choice?

26 August 2022

Congress Presentation

2 September 2019

Congress Presentation

A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources